NewsRx

Search our medical news database

Cleveland Clinic Foundation

Cleveland Clinic spin-off Symphony Medical raises $6M to develop treatments for AF

Published in Cardiovascular Business Week, March 28th, 2006

Symphony Medical, Inc., a Cleveland Clinic spin-off company, recently raised more than $6 million in equity funding to develop treatments for atrial fibrillation (AF) and other ailments.

A biopharmaceutical company with offices in Cleveland Clinic's Innovation Center, Minnesota, and California, Symphony will use the funding to increase its staff size, complete clinical trials, and introduce a new product in Europe aimed at preventing atrial fibrillation after surgery.

The company's latest financing round included a new investor, Triathlon Medical Ventures, and existing investors, Morgehnthaler Ventures, Domain Associates, and Guidant Compass Group....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook